EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg) HCP: 45 Social Audience

EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg) HCP Overview

Website: hcp.epclusa.com
Industry: Pharmaceutical Manufacturing
Employees: 1
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

About EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg) HCP

Please see full Prescribing Information for EPCLUSA, including BOXED WARNING, at https://bit.ly/3mw8Klx and at hcp.EPCLUSA.com. To report SUSPECTED ADVERSE REACTIONS, contact Gilead Sciences, Inc. at 1-800-GILEAD-5 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. EPCLUSA, the EPCLUSA Logo, GILEAD, and the GILEAD Logo are trademarks of Gilead Sciences, Inc., or its related companies. ©2024 Gilead Sciences, Inc. All rights reserved. US-EPCP-0484 07/24